3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
25
Phase 1/2
14
Phase 2
6
Phase 2/3
3
Phase NA
1
Phase EARLY_PHASE1
1
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3865
Neoplasms
2990
Prostatic Neoplasms
1754
Colorectal Neoplasms
1431
Lung Neoplasms
1331
Motor Activity
805
Head and Neck Neoplasms
686
Pancreatic Neoplasms
663
Colonic Neoplasms
655
Uterine Cervical Neoplasms
653
Carcinoma, Hepatocellular
632
Carcinoma, Non-Small-Cell Lung
631
Rectal Neoplasms
571
Stomach Neoplasms
547
Brain Neoplasms
486
Ovarian Neoplasms
441
Anxiety Disorders
420
Pain
419
Neoplasm Metastasis
385
Esophageal Neoplasms
384
Polycystic Ovary Syndrome
376
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Urinary Bladder Neoplasms
351
Fatigue
340
Melanoma
323
Multiple Myeloma
322
Lymphoma
306
Depression
306
Endometrial Neoplasms
290
Liver Neoplasms
280
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Interventional
×
Adenoviridae Infections
×
Clear all
NCT02108522
2021-07-20
CHARMS
AlloVir
Phase NA
Completed
82 enrolled
20 charts